Lincoln Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on April 16, 2015, to finalize the issue of convertible warrants on preferential basis to the Promoters/Promoters group and Non promoters also and further to decide about the date of Extra Ordinary general Meeting for obtaining approval of members of the Company for the preferential issue of convertible warrants.
For Quick Alerts
For Daily Alerts
For investment related articles, business news and mutual fund advise
You have already subscribed